Table 4.

Linear Mixed Model of Size of Anal Warts and HIV Load of the Women’s Interagency HIV Study HIV-Infected Participants in Current Study

	Unadjusted Model		Adjusted Modele
	Estimates ± SD	P Value	Estimates ± SD	P Value
Intercept	38.73 ± 18.73	.03f	17.92 ± 34.36	.60
Visit	0.47 ± 1.58	.77	−2.68 ± 7.37	.71
Viral load <4000 copies/mL	0a		0c
Viral load 4000–20 000 copies/mL	−17.35 ± 33.23	.60	−1.22 ± 17.53	.94
Viral load 20 001–100 000 copies/mL	−58.97 ± 30.15	.05	2.32 ± 15.68	.88
Viral load >100 000 copies/mL	−41.40 ± 29.05	.15	19.97 ± 15.39	.20
Visit (Viral load <4000 copies/mL)	0b		0d
Visit (Viral load 4000–20 000 copies/mL copies/mL)	1.40 ± 3.06	.65	−0.61 ± 3.79	.87
Visit (Viral load 20 001–100 000 copies/mL)	8.97 ± 2.99	.003f	0.53 ± 3.24	.87
Visit (Viral load >100 000 copies/mL)	3.67 ± 3.00	.22	−3.25 ± 3.51	.36

Abbreviation: SD, standard deviation.

^aType 3, P = .21.

^bType 3, P = .02.

^cType 3, P = .52.

^dType 3, P = .76.

^eModel adjusted for no. of sex partners in the last 6 months, race, highly active antiretroviral therapy use, enrollment, marital status, annual household income, and education level.

^fStatistically significant at P value < .05.